TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups—A meta-analysis of aggregate data-Reference-Cited by-同舟云学术

TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups—A meta-analysis of aggregate data

Published:2017-12 Issue: Volume:120 Page:1-9
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Vuong Huy Gia,Altibi Ahmed M.A.,Duong Uyen N.P.,Ngo Hanh T.T.,Pham Thong Quang,Chan Aden Ka-Yin,Park Chul-Kee,Fung Kar-Ming,Hassell Lewis

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference50 articles.

1. Radiotherapy plus concomitant temozolomide in primary gliosarcoma;Adeberg;J. Neurooncol.,2016

2. A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas;Arita;Acta Neuropathol. Commun.,2016

3. TERT Promoter Mutations and Prognosis in Solitary Fibrous Tumor;Bahrami;Mod. Pathol.,2016

4. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism;Batista;Int. J. Cancer,2016

5. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas;Brat;N. Engl. J. Med.,2015

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Profile as an Outcome Predictor in Glioblastoma along with MRI Features and Surgical Resection: A Scoping Review;International Journal of Molecular Sciences;2024-09-08

2. Diffusion-weighted MRI precisely predicts telomerase reverse transcriptase promoter mutation status in World Health Organization grade IV gliomas using a residual convolutional neural network;British Journal of Radiology;2024-08-17

3. 1p19q co-deletion is an independent prognostic factor in glioma with TERT promoter mutations;2024-08-17

4. Recursive partitioning analysis for survival stratification and early imaging prediction of molecular biomarker in glioma patients;BMC Cancer;2024-07-09

5. Dissecting the prognostic signature of patients with astrocytoma isocitrate dehydrogenase-mutant grade 4: a large multicenter, retrospective study;ESMO Open;2024-06